Citi tips Flight Centre share price as a buy

Flight Centre Travel Group Ltd (ASX: FLT): Buy, hold, sell?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The best Australian travel shares such as Flight Centre Travel Group Ltd (ASX: FLT), Webjet Limited (ASX: WEB), Helloworld Ltd (ASX: HLO) and Corporate Travel Management Ltd (ASX: CTD) have been under pressure recently for differing reasons, but Flight Centre shares could have some upside if the analysts at Citi are on the money. 

News wires are reporting that Citi's tipping the Flight Centre share price as a buy at $43.40 after the shares lost around 33% over the past 12 months partly on the back of an April 2019 downgrade to full year profit guidance.

Flight Centre now expects full year profit before tax between $335 million to $360 million, which is a fair way lower than the original guidance between $390 million to $420 million. 

Flight Centre blamed the downgrade on Australia's weaker domestic economy paring back leisure and business travel demand, with the same problem affecting Brexit-stranded Britain. 

It's not hard to see why Flight Centre might be liked by Citi as based on a 101 million shares on issue it has a market value of $4.38 billion, which is just 12.6x the mid-point of its net profit forecast. Moreover, it has an extremely strong balance sheet with just $35.8 million in debt and $394 million cash on hand. 

It also has a long-term track record of growth and is founder led to mean it ticks the boxes for further research. 

Motley Fool contributor Tom Richardson has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Flight Centre Travel Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »